Tweetovi

Blokirali ste korisnika/cu @psandiego

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @psandiego

  1. 2. pro 2019.

    The JLABS @ Washington DC Children’s is now accepting ideas through 4/24/20 with the aim to impact pediatric oncology, pediatric surgical care, & influenza! Apply for up to $150K in grant funding, residency, & mentoring

    Poništi
  2. 25. stu 2019.

    JLABS empowers innovators to change the trajectory of human health – and you can help! Join the team at our newest location opening in 2020, as the Business Operations Sr. Lead at JLABS @ Washington, DC.

    Poništi
  3. 25. stu 2019.

    Congratulations to the JLABS @ BE resident company Caelus Health. The company has signed an exclusive global development & option agreement with Nestlé Health Science for the development of their microbiome-based food supplements f…

    Poništi
  4. 22. stu 2019.

    Please see this excellent profile about San Francisco’s Quest to Make Landfills Obsolete via

    Poništi
  5. 21. stu 2019.

    Congratulations to NERv Technology a recent awardee, for winning the at the MISK Global Forum 👏

    Poništi
  6. 19. stu 2019.
    Poništi
  7. 19. stu 2019.

    alumnus, Inflammatix_Inc and BARDA expand partnership. BARDA will support the advanced development of the novel testing technology, under a 14-month, $6 million contract. Inflammatix is developing three diagnostic tests…

    Poništi
  8. 13. stu 2019.
    Poništi
  9. 13. stu 2019.

    Two exciting funding announcements today for JLABS @ San Diego alumni companies. Avidity Biosciences announced the completion of a $100M series C financing and EpicentRX announced the raise of a $35M series D financing. Avidity Bi…

    Poništi
  10. 5. stu 2019.

    Coda Series A Extension, brings total round to $34 Million Congratulations, JLABSBay Alumnus, CODA Biotherapeutics, Inc., a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform to treat in…

    Poništi
  11. 9. lis 2019.

    Our JLABS site in Belgium was listed in Labiotech’s list of The 20 Best Biotech Incubators Hatching Startup Stars in Europe. JLABS is a network of life science incubators empowering and enabling innovators to deliver life-enhanci…

    Poništi
  12. 8. lis 2019.

    Sally Allain, our new Head of JLABS @ Washington, DC, sits down to discuss what excites her most about opening a in the nation’s capital and what she hopes to bring to start-ups working to develop breakthrough solutions for…

    Poništi
  13. 2. lis 2019.

    “Thanks to strong support from the Chinese Government and a favorable policy environment, China has a vibrant life-science ecosystem that is rapidly evolving to meet the growing healthcare needs of its people, including changing li…

    Poništi
  14. 2. lis 2019.

    Congratulations to Carcinogenic Exposure awardee PExA on their newly announced research collaboration with Janssen Research & Development, LLC and the University of Gothenburg! Learn more about PExA on the Navigator at

    Poništi
  15. 16. ruj 2019.

    JLABS @ SSF resident, Hummingbird Bioscience announces collaboration with Amgen to Co-Discover Novel Therapeutics Using Hummingbird’s Rational Antibody Discovery Platform Hummingbird Bioscience, an innovative systems-biology enabl…

    Poništi
  16. 9. kol 2019.

    Start spreading the news! Johnson & Johnson Innovation - JLABS is hiring the Head, Johnson & Johnson Innovation - JLABS @ NYC, Boston & Philadelphia | New York, New York. Join the and help change the trajectory of hea…

    Poništi
  17. 8. kol 2019.

    JLABS @ SSF resident, Hummingbird Bioscience and Cancer Research UK, the world’s leading cancer charity, announced a partnership to develop Hummingbird’s anti-HER3 antibody drug, HMBD-001, for the treatment of people with HER3 driv…

    Poništi
  18. 8. kol 2019.

    An exciting announcement for JLABS @ Toronto resident company, BlueRock Therapeutics, who has been acquired by Bayer. The investment corresponds to a total company value of approximately USD 1 billion. BlueRock Therapeutics' portfo…

    Poništi
  19. 1. srp 2019.

    From a handful companies at the start of in 2012, to 560+ globally today – reflects on the purpose & impact of on the innovation ecosystem in San Diego and beyond. Read the article:

    Poništi
  20. 27. lip 2019.

    Hear why we co-located the site with our Shanghai Discovery Center to support our commitment to help build the local innovation ecosystem in Asia. "It's great to see our dream finally become a reality." - Mark Bach,…

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·